Clinical prediction rules: new opportunities for pharma

Drug Discovery Today

Volumn 14, Issue 23-24, 2009, Pages 1143-1149

  Herscu, Paul ^a   Hoover, Todd A ^a   Randolph, Adrienne G ^b  

^a Research Division   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PROVENGE;

CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL PREDICTION RULE; DEPRESSION; DRUG EFFICACY; DRUG MARKETING; DRUG RESEARCH; DRUG TREATMENT FAILURE; EVIDENCE BASED MEDICINE; HEALTH ECONOMICS; HUMAN; MEDICAL INFORMATICS; MEDICAL INFORMATION SYSTEM; MOLECULAR GENETICS; OUTCOME ASSESSMENT; PHARMACODYNAMICS; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREDICTION; PROGNOSIS; PROSTATE CANCER; REPRODUCIBILITY; REVIEW; STATISTICAL ANALYSIS; VALIDATION PROCESS;

CLINICAL TRIALS AS TOPIC; DECISION SUPPORT SYSTEMS, CLINICAL; DECISION SUPPORT TECHNIQUES; DRUG INDUSTRY; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; PROBABILITY; PROGNOSIS;

EID: 71749083145     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2009.09.012     Document Type: Review

References (25)

1. Wasson J.H., et al. Clinical prediction rules. Applications and methodological standards. N. Engl. J. Med. 313 (1985) 793-799
2. Laupacis A., et al. Clinical prediction rules. A review and suggested modifications of methodological standards. J. Am. Med. Assoc. 277 (1997) 488-494
3. Randolph A.G., et al. Understanding articles describing clinical prediction tools. Evidence Based Medicine in Critical Care Group. Crit. Care Med. 26 (1998) 1603-1612
4. Reilly B.M., and Evans A.T. Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Ann. Intern. Med. 144 (2006) 201-209
5. Wisnivesky J.P., et al. Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch. Intern. Med. 160 (2000) 2471-2476
6. McGinn T.G., et al. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. J. Am. Med. Assoc. 284 (2000) 79-84
7. Rudy T., et al. Multivariate analysis and repeated measurements: a primer. J. Crit. Care 7 (1992) 30-41
8. Cook E.F., and Goldman L. Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis. J. Chronic Dis. 37 (1984) 721-731
9. Baxt W.G. Application of artificial neural networks to clinical medicine. Lancet 346 (1995) 1135-1138
10. Bellazzi R., and Zupan B. Predictive data mining in clinical medicine: current issues and guidelines. Int. J. Med. Inform. 77 (2008) 81-97
11. Olivotto I.A., et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J. Clin. Oncol. 23 (2005) 2716-2725
12. Gage B.F., et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110 (2004) 2287-2292
13. Crespo-Facorro B., et al. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables. J. Psychiatr. Res. 41 (2007) 659-666
14. Yamada H., et al. Efficacy prediction of cevimeline in patients with Sjogren's syndrome. Clin. Rheumatol. 26 (2007) 1320-1327
15. Kanetaka H., et al. Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion. Nucl. Med. Commun. 29 (2008) 568-573
16. Dahri K., and Loewen P. The risk of bleeding with warfarin: a systematic review and performance analysis of clinical prediction rules. Thromb. Haemost. 98 (2007) 980-987
17. Morimoto T., et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J. Eval. Clin. Pract. 10 (2004) 499-509
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 29 Suppl. 1 (2006) S43-S48
19. Marrie T.J., et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. J. Am. Med. Assoc. 283 (2000) 749-755
20. Selker H.P., et al. Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial. Ann. Intern. Med. 129 (1998) 845-855
21. Stiell I., et al. Multicentre trial to introduce the Ottawa ankle rules for use of radiography in acute ankle injuries. Multicentre Ankle Rule Study Group. BMJ 311 (1995) 594-597
22. Nugent P.J. Ottawa ankle rules accurately assess injuries and reduce reliance on radiographs. J. Fam. Pract. 53 (2004) 785-788
23. Small E.J., et al. Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J. Clin. Oncol. 24 (2006) 3089-3094
24. Healy D. Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression (2004), NYU Press
25. Rochais F., et al. Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol. J. Clin. Invest. 117 (2007) 229-235